1. Home
  2. THS vs GERN Comparison

THS vs GERN Comparison

Compare THS & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THS
  • GERN
  • Stock Information
  • Founded
  • THS 2021
  • GERN 1990
  • Country
  • THS United States
  • GERN United States
  • Employees
  • THS N/A
  • GERN N/A
  • Industry
  • THS Packaged Foods
  • GERN Biotechnology: Pharmaceutical Preparations
  • Sector
  • THS Consumer Staples
  • GERN Health Care
  • Exchange
  • THS Nasdaq
  • GERN Nasdaq
  • Market Cap
  • THS 2.1B
  • GERN 2.5B
  • IPO Year
  • THS N/A
  • GERN 1996
  • Fundamental
  • Price
  • THS $42.19
  • GERN $4.06
  • Analyst Decision
  • THS Hold
  • GERN Strong Buy
  • Analyst Count
  • THS 6
  • GERN 9
  • Target Price
  • THS $40.00
  • GERN $6.83
  • AVG Volume (30 Days)
  • THS 312.4K
  • GERN 7.9M
  • Earning Date
  • THS 11-12-2024
  • GERN 11-07-2024
  • Dividend Yield
  • THS N/A
  • GERN N/A
  • EPS Growth
  • THS N/A
  • GERN N/A
  • EPS
  • THS N/A
  • GERN N/A
  • Revenue
  • THS $3,383,300,000.00
  • GERN $1,373,000.00
  • Revenue This Year
  • THS $1.73
  • GERN $23,693.67
  • Revenue Next Year
  • THS $3.52
  • GERN $401.91
  • P/E Ratio
  • THS N/A
  • GERN N/A
  • Revenue Growth
  • THS N/A
  • GERN 205.11
  • 52 Week Low
  • THS $33.28
  • GERN $1.64
  • 52 Week High
  • THS $43.84
  • GERN $5.34
  • Technical
  • Relative Strength Index (RSI)
  • THS 59.36
  • GERN 39.25
  • Support Level
  • THS $40.41
  • GERN $4.11
  • Resistance Level
  • THS $42.37
  • GERN $4.37
  • Average True Range (ATR)
  • THS 0.72
  • GERN 0.17
  • MACD
  • THS 0.11
  • GERN -0.03
  • Stochastic Oscillator
  • THS 92.91
  • GERN 20.27

About THS Treehouse Foods Inc.

TreeHouse Foods is the largest pure-play private-label manufacturer in the US. Much larger in the past following the 2016 acquisition of Ralcorp, Conagra's former private-label business, the company has since divested several businesses to focus on high-growth categories. At present, the company produces and sells snacks (crackers, pretzels, cookies, and so on), beverages and drink mixes (such as nondairy creamer, coffee, tea), and a select number of grocery products (pickles, refrigerated dough, hot cereal, cheese, and pudding). Its most important sales channel is through retail grocery stores that sell its products under their own brands, with co-manufacturing and food away from home as much smaller channels of distribution for its fare.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: